Evaluating Cell Function Through VC Cell Therapy’s Experience with VisionSort® in Regenerative Medicine
VCCT’s Challenge: Evaluating Cell Quality for Clinical Translation Guided by its vision, “Providing all solutions for all patients,” VC Cell Therapy Inc. (VCCT) is working to realize cell therapies for outer retinal diseases. At VCCT, Dr. Tomohiro Masuda leads manufacturing development and quality control, two functions central to the company’s R&D. To evaluate cell quality beyond conventional methods, Dr. Masuda introduced VisionSort®, a cell sorter equipped with ThinkCyte’s Ghost Cytometry® (hereafter GC) technology. For cellular products, evaluating and managing cell characteristics is essential when defining release criteria. For teams working from basic research through clinical-grade products, this remains a persistent R&D challenge. Even as two iPS-derived cellular products received their […]
